Abstract
The evidence for a GABA receptor which was distinct from the classical chloride-dependent ionotropic receptor first emerged in mammalian peripheral tissues (Bowery et al 1981; see Bowery 1989). In a variety of isolated nerve-smooth muscle and atrial muscle preparations, GABA and its analogue, ß-chlorophenyl GABA (baclofen), were shown to depress the contractile response to nerve stimulation. A typical example of this is shown in Figure 1 where increasing concentrations of baclofen produced a decrease in contraction of the twitch response of the rat anoccocygeus muscle. This reduction in contraction was produced by a decrease in transmitter release from the autonomic innervation. No evidence for any effect at the postsynaptic site was observed. Thus, in general, the influence of GABA was restricted to the nerve input and could be construed as acting on the presynaptic release mechanism in peripheral tissues. The characteristics of the receptor mediating this effect showed little resemblance to the established GABA receptor but it seemed unlikely that it had any physiological significance, perhaps with the exception of the enteric nervous system where GABA neurones have been demonstrated (see Kerr & Ong 1995).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Battaglia, G., Rustioni, A. (1988). Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey. J. Comp. Neurol., 277, 302.
Bonanno, G., Raiteri, M. (1993). Multiple GABAB receptors. Trends Pharmacol. Sci., 14: 259–261.
Bowery, N.G. (1989). GABAB receptors and their significance in mammalian pharmacology. Trends Pharmacol. Sci. 10, 401–407.
Bowery, N.G., (1993). GABAB Receptor Pharmacology. Annu. Rev. Pharmacol. Toxicol. 109–147.
Bowery, N.G., Doble, A., Hill, D.R., Hudson, A.L., Shaw, J.S., Turnbull, M.J. and Warnngton, R. (1981). Bicuculline-insenstive GABA receptor on peripheral autonomic nerve terminals. Eur. J. Pharmacol. 71: 53–70.
Bowery, N.G., Hill, D.R., and Hudson A.L. (1983). Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes, Br. J. Pharmacol. 78, 191.
Bowery, N.G., Hill, D.R., Hudson, A.L., Doble, A., Middlemiss, D.N., Shaw J. and Turnbull, M. (1980) (-) Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 283: 92–94.
Castro-Lopes, J.M., Malcangio, M., Pan, B.H., Bowery, N.G. (1995). Complex changes of GABAA and GABAB receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy. Brain Research 679, 289–297.
Castro-Lopes, J.M., Tavares, I., Tolle, T.R., Coito, A., Coimbra, A. (1992). Increase in GABAergic cells and GABA levels in the spinal cord in unilateral inflammation of the hindlimb of the rat. Eur. J. Neurosci, 4, 296–301.
Crunelli, V., Leresche, N. (1991). A role for GABAB receptors in excitation and inhibition of thalamocortical cells. Trends Neurosci. 14:16–21.
De Biasi, S., Rustioni, A. (1988). Glutamate and substance P co-exist in primary afferent terminals in the superficial laminae of spinal cord. Proc. Natl. Acad. Sci. USA 85, 7820–7824.
Deisz, R. A., Billard, J.M. and Zieglgansberger, W. (1993). Pre and postsynaptic GABAB receptors of rat neocortical neurones differ in their pharmacological properties. Neuroscience Letters 154, 209–212.
Donnerer, J., (1991). Depolarization-evoked release of glutamate, aspartate and γ- aminobutyric acid from rat dorsal spinal cord slices does not originate from capsaicinsenstive neurons, Brain Res. 555, 332.
Dutar, P., Nicoll, R.A. (1988a). A physiological role for GABAB receptors in the central nervous system. Nature 332:156–158.
Dutar, P., Nicoll, R.A. (1988b). Pre-and postsynaptic GABAB receptors in the hippocampus have different pharmacological properties. Neuron 1: 585–598.
Gemignani, A., Paudic, P., Bonanno, G. and Raiteri M. (1994). Pharmacological Discrimination Between γ-Aminobutyric Acid Type B Receptors Regulating Cholecystokinin and Somatostatin Release from Rat Neocortex Synaptosomes. Mol. Pharmacol., 45, 558–562.
Giovannini, G., Lacey M.G., Pepeu G., Nistri, A. (1991). Release of endorgenous glutamate and aspartate from frog spinal cord in vitri. Eur. J. Pharmacol., 195, 47.
Hargreaves, K., Dubner, R., Brown, F., Flores, C, Joris, J. (1988). A new and sensitive method for measuring thermal nmociception in cutaneous hyperalgesia. Pain, 32, 77–88.
Harrison, N.L. (1990). On the presynaptic action of baclofen at inhibitory synapses between cultured rat hippocampal neurones. J. Physiol. 422: 433–446.
Hill, D.R., Bowery, N.G. (1981) 3H-Baclofen and 3H-GABA bind to bicucullineinsensitive GABAB sites in rat brain. Nature 290:149–152.
Isaacson, J.S., Solis, J.M. and Nicoll, R.A. (1993). Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 10:165–175.
Kangrga, I., Jiang, M. Randic, M. (1991). Action of (-)baclofen on rat dorsal horn neurones. Brain Res. 562, 265.
Kangrga, I., Larew J.S.A., Randic, M. (1990). The effects of substance P and calcitonin-gene-related peptide on the efflux of endogenous glutamate and aspartate from rat spinal dorsal horn in-vitro. Neurosci. Lett., 108, 155.
Kangrga, I., Randic, M. (1991). Outflow of endogenous amino acids from the rat spinal dorsal horn slice in response to low- and high-threshold primary afferent fibres. Modulation of µ-opioids, Brain Res. 553, 347.
Kar, S., Gibson, S.J., Rees, R.G., Jura, W.G.Z.O., Brewerton, D.A., Polak, J.M. (1991). Increased calcitonin-gene-related peptide (CGRP), substance P and enkephalin immunoreactivities in dorsal spinal cord and loss of CGRP-immunoreactive motoneurons in arthritic rats depend on intact peripheral nerve supply. J. Mol. Neurosci. 3, 7–18.
Karlsson, G., Pozza, M. and Olpe, H.-R. (1988). Phaclofen: a GABAB blocker reduces long-duration inhibition in the neocortex. Eur. J. Pharmacol. 148: 485–486.
Kerr, D.I.B. and Ong, J. (1995). GABAB receptors. Pharmac. Ther., 67, 187–246.
Magoul, R. Onteniente, B., Geffard, M. & Calas, S. (1987). Anatomical distribution and ultrastructural organization of the GABAergic system in the rat spinal cord. An immunocytochemical study using anti-GABA antibodies. Neuroscience, 20, 1001–1009.
Malcangio, M., Bowery, N.G. (1993). γ-Aminobutyric acidB, but not γ-aminobutyric acidA receptor activation, inhibits electrically-evoked substance P-like immunoreactivity from rat spinal cord in vitro. J. Pharmacol. Exp. Ther., 266, 1490–1496.
Malcangio, M, Bowery, N.G. (1993). Gamma-aminobutyric acidB but not ammaamino butyric and acidA receptor activation inhibits electrically evoked substance Plike immunoreactivity release from the rat spinal cord in Vitro. J. Pharmac. Exp. Ther., 266, 1490–1496.
Malcangio, M. and Bowery, N.G. (1994). Spinal cord SP release and hyperalgesia in monoarthritic rats: involvement of the GABAB receptor system. Br. J. Pharmacol. 113:1561–1566.
Malcangio, M., and Bowery, N.G. 1994. Spinal cord SP release and hyperalgesia in onoarthritic rats: involvement of the GABAB receptor system. Br. J. Pharmacol. 13, 1561.
Malcangio, M., Libri, V., Teoh, H., Constanti, A. and Bowery, N.G. (1995). Chronic (-) baclofen or CGP 36742 alters GABAB receptor senstivity in rat brain and spinal cord. Neuroreport, 6: 339–403.
Malcangio, M., Libri, V., Teoh, H., Constanti, A., Bowery, N.G. (1995). Chronic (-) baclofen or CGP 36742 alters GABAB receptor sensitivity in rat brain and spinal cord. Neuroreport 6, 399–403.
Malcangio, M., Silva Da H., Bowery N.G. (1993). Plasticity of GABAB receptor in rat spinal cord detected by autoradiography, Eur. J. Pharmacol. 250, 153.
Minami, M., Kuraishi, Y., Kawamura, M., Yamaghuchi, T., Masu, Y., Nakanishi, S., Satoh, M. (1989). Enhancement of preprotachykinin in the rat spinal cord: possible involvement of substance P-containing spinal neurons in nociception. Neurosci. Lett., 98, 105–110.
Mott, D.D., Lewis, D.L. The pharmacology and function of GABAB receptors. Int. Rev. Neurobiol. 36: 97–223, 1994.
Oku, R., Satoh, M. & Tagaki, H., (1987). Release of substance P from the spinal dorsal horn is enhanced in polyarthritic rats. Neurosci. Lett., 74, 315–319.
Penn, R.D., Savoy, S.M., Corcos, D., Latash, M., Gottlieb, G., et al. 1989. Intrathecal baclofen for severe spinal spasticity. N. Engl. J. Med. 320:1517–21.
Penn, R.R. and Mangieri, E.A. (1993). Stiff-man syndrome treated with intrathecal baclofen. Neurology 43: 2412.
Pittaluga, A., Asaro, D., Pettegrinni, G. and Raiteri, M. (1987). Studies of 3H-GABA and endogenous GABA release in rat cerebral cortex suggest the presence of autoreceptors of the GABAB type. Eur. J. Pharmacol. 144: 45–52.
Pratt, G.D., Bowery, N.G. (1993). Repeated administration of desipramine and a GABAB receptor antagonist, CGP 36742, discretely up-regulates rat frontal cortical GABAB receptor binding sites. Br. J. Pharmacol., 110, 724–735.
Price, G.W. Kelly, J.S., Bowery, N.G. (1987). The location of GABAB receptor binding sites in mammalian spinal cord. Synapse 1:530–38.
Price, G.W., Blackburn, T.P., Hudson, A.L. Bowery, N.G. 1984. Presynaptic GABAB sites in the interpeduncular nucleus. Neuropharmacology 23:861–62.
Raiteri, M., Giralt, M.T., Bonanno, G., Pittaluga, A., Fedele, E. and Fontana, G. (1990). Release-regulating GABA autoreceptors in human and rat central nervous system. In: GABAB receptors in mammalian function. Eds: Bowery, N.G., Bittiger, H. & Olpe H.-R. Publ. Wiley, Chichester pp 81–98.
Skilling, S.R., Larson, A.A. (1993). Capsaicin inhibits whereas rhizotomy potentiates substance P-induced release of excitatory amino acids in the rat spinal cord in vivo. Neurosci. Lett. 150, 107.
Sluka, K.A., Dougherty, P.M., Okin, L.S., Willis, W.D., Westlund, K.N. (1992). Neuronal changes in acute arthritis in monkey III. Changes in subtance P, CGRP and glutamate in the dorsal horn of the spinal cord. Brain Res. Rev., 17, 29–38.
Teoh, H., Malcangio, M., and Bowery N.G. (1996a). The effects of novel GABAB antagonists on the release of amino acids from spinal cord of the rat. Br. J. Pharmacol. (in press).
Teoh, H., Malcangio, M., Fowler, L.J. & Bowery, N.G. (1996b). Evidence for release of glutamic acid, aspartic acid and substance P but not γ-aminobutyric acid from primary afferent fibres in rat spinal cord. Eur. J. Pharmacol (in press).
Todd, A.J. & McKenzie, J. (1989). GABA-immunoreactive neurons in the dorsal horn of the rat spinal cord. Neuroscience, 3 1, 799–806.
Waldmeier, P.C., Wicki, P., Feldtrauer, J.-J., Mickel, S.J. Bittiger, H. and Baumann, P.A. (1994). GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors. Br. J. Pharmacol. 113, 151–1521.
Waldovogel, H.J., Faull, R.L.M., Jansen, K.L.R, Dragunow, J., Richards, J.G., Mohler, H., Streit, P., (1990). GABA. GABA receptors and benzodiazepine receptors in the human spinal cord: an autoradiographic and immunohistochemical study at the light and electron microscopic levels. Neuroscience 39, 361.
Westlund, K.N., McNeill, D.L., Patterson, J.T. Coggeshall, R.E. (1989b). Aspartate immunoreactive axons in normal rat L4 dorsal roots. Brain Res. 489, 347.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bowery, N.G., Malcangio, M., Teoh, H. (1997). GABAB Receptor Control of Neurotransmitter Release in Mammalian Brain: Modification During Chronic Inflammation. In: Pöğün, Ş. (eds) Neutrotransmitter Release and Uptake. NATO ASI Series, vol 100. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60704-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-60704-2_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64517-4
Online ISBN: 978-3-642-60704-2
eBook Packages: Springer Book Archive